Fosamprenavir Calcium Patent Expiration
Fosamprenavir Calcium is Used for managing and treating HIV infection. It was first introduced by Viiv Healthcare Co
Fosamprenavir Calcium Patents
Given below is the list of patents protecting Fosamprenavir Calcium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lexiva |
US6514953 (Pediatric) | Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
Jan 15, 2020
(Expired) | Viiv Hlthcare |
| Lexiva | US6514953 | Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
Jul 15, 2019
(Expired) | Viiv Hlthcare |
| Lexiva |
US6436989 (Pediatric) | Prodrugs of aspartyl protease inhibitors |
Jun 24, 2018
(Expired) | Viiv Hlthcare |
| Lexiva | US6436989 | Prodrugs of aspartyl protease inhibitors |
Dec 24, 2017
(Expired) | Viiv Hlthcare |
Fosamprenavir Calcium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List